Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Good
|
|
Filing tables
Filing exhibits
- 10-K Annual report
- 10.61 Offer Letter
- 10.62 Amendment No. 3 to 2001 Agreement
- 10.63 Amendment No. 1 - Notice of Grant of Stock Option
- 10.64 General Release and Settlement Agreement
- 10.65 Consulting Agreement
- 10.66 Stock Purchase Agreement
- 10.67 Amendment No. 1 to Rights Agreement
- 10.68 Stock Purchase Agreement
- 10.69 Stock Purchase Agreement
- 21.1 List of Subsidiaries
- 23.1 Consent of Ernst & Young
- 99.1 Certification of CEO
- 99.2 Certification of CFO
INFIQ similar filings
Filing view
External links
EXHIBIT 21.1 |
| Name | Jurisdiction of Incorporation | ||
|---|---|---|---|
| Discovery Partners International AG | Switzerland | ||
| ChemRx Advanced Technologies, Inc. | Delaware | ||
| Structural Proteomics, Inc. | New Jersey | ||
| Systems Integration Drug Discovery Company, Inc. | Arizona | ||
| Xenometrix, Inc. | Delaware | ||
| Irori Europe, Ltd. | United Kingdom | ||